参考文献/References:
[1] Potters L,Kavanagh B,Galvin JM,et al. American Society for Therapeutic Radiology and Oncology(ASTRO) and American College of Radiology(ACR) practice guideline for the performance of stereotactic body radiation therapy[J]. Int J Radiat Oncol Biol Phys,2010,76(2):326-332.
[2] Timmerman RD,Kavanagh BD,Cho LC,et al. Stereotactic body radiation therapy in multiple organ sites[J]. J Clin Oncol,2007,25(8):947-952.
[3] Chang JH,Cha MJ,Seo JW,et al. Feasibility study on stereotactic radiotherapy for total pulmonary vein isolation in a canine model[J]. Sci Rep,2021,11(1):12369.
[4] Loo BW Jr,Soltys SG,Wang L,et al. Stereotactic ablative radiotherapy for the treatment of refractory cardiac ventricular arrhythmia[J]. Circ Arrhythm Electrophysiol,2015,8(3):748-750.
[5] Paul CZ,Edward AG,Thomas F,et al. P1809 Noninvasive cardiac radiosurgery:current clinical experience for treatment of refractory arrhythmias[J]. Europace,2017,40(supple 1):ehz748.0500
[6] Cuculich PS,Schill MR,Kashani R,et al. Noninvasive cardiac radiation for ablation of ventricular tachycardia[J]. N Engl J Med,2017,377(24):2325-2336.
[7] Robinson CG,Samson PP,Moore KMS,et al. Phase Ⅰ/Ⅱ trial of electrophysiology-guided noninvasive cardiac radioablation for ventricular tachycardia [J]. Circulation,2019,139(3):313-321.
[8] Cuculich P.HRS 2020:Longer Term Results from the ENCORE-VT Study[Z].2020https://www.radcliffecardiology.com/video-index/hrs-2020-longer-results-encore-vt-study.
[9] Neuwirth R,Cvek J,Knybel L,et al. Stereotactic radiosurgery for ablation of ventricular tachycardia[J]. Europace,2019,21(7):1088-1095.
[10] Arkles J,Markman T,Trevillian R,et al. One-year outcomes after stereotactic body radiotherapy for refractory ventricular tachycardia[J]. Heart Rhythm,2024,21(1):18-24.
[11] van der Ree MH,Dieleman EMT,Visser J,et al. Non-invasive stereotactic arrhythmia radiotherapy for ventricular tachycardia:results of the prospective STARNL-1 trial[J]. Europace,2023,25(3):1015-1024.
[12] Miszczyk M,Hoeksema WF,Kuna K,et al. Stereotactic arrhythmia radioablation(STAR)-a systematic review and meta-analysis of prospective trials on behalf of the STOPSTORM.eu consortium [J]. Heart Rhythm,2025,22(1):80-89.
[13] Gupta A,Sattar Z,Chaaban N,et al. Stereotactic cardiac radiotherapy for refractory ventricular tachycardia in structural heart disease patients:a systematic review[J]. Europace,2024,27(1):euae305.
[14] Wei C,Boeck M,Qian PC,et al. Cost of cardiac stereotactic body radioablation therapy versus catheter ablation for treatment of ventricular tachycardia[J]. Pacing Clin Electrophysiol,2022,45(9):1124-1131.
[15] Sharma A,Wong D,Weidlich G,et al. Noninvasive stereotactic radiosurgery(CyberHeart) for creation of ablation lesions in the atrium[J]. Heart Rhythm,2010,7(6):802-810.
[16] Bode F,Blanck O,Gebhard M,et al. Pulmonary vein isolation by radiosurgery:implications for non-invasive treatment of atrial fibrillation[J]. Europace,2015,17(12):1868-1874.
[17] Monroy E,Azpiri J,De la Pe?a C,et al. Late gadolinium enhancement cardiac magnetic resonance imaging post-robotic radiosurgical pulmonary vein isolation(RRPVI):first case in the world[J]. Cureus,2016,8(8):e738.
[18] Qian PC,Azpiri JR,Assad J,et al. Noninvasive stereotactic radioablation for the treatment of atrial fibrillation:First-in-man experience[J]. J Arrhythm,2020,36(1):67-74.
[19] Bonaparte I,Gregucci F,di Monaco A,et al. Phase Ⅱ trial of LINAC-based STereotactic Arrhythmia Radioablation (STAR) for paroxysmal atrial fibrillation in elderly:planning and dosimetric point of view[J]. J Pers Med,2023,13(4) :596.
[20] Sakakura K,Tunev S,Yahagi K,et al. Comparison of histopathologic analysis following renal sympathetic denervation over multiple time points[J]. Circ Cardiovasc Interv,2015,8(2):e001813.
[21] Rousselle SD,Brants IK,Sakaoka A,et al. Neuromatous regeneration as a nerve response after catheter-based renal denervation therapy in a large animal model:immunohistochemical study[J]. Circ Cardiovasc Interv,2015,8(5):e002293.
[22] Booth LC,Nishi EE,Yao ST,et al. Reinnervation of renal afferent and efferent nerves at 5.5 and 11 months after catheter-based radiofrequency renal denervation in sheep[J]. Hypertension,2015,65(2):393-400.
[23] Cai XX ,Yang YL,Shen YC,et al. Noninvasive stereotactic radiotherapy for renal denervation in a swine model[J]. J Am Coll Cardiol,2019,74(13):1697-1709.
[24] Cai X,Shen Y,Yang Y,et al. Renal denervation by noninvasive stereotactic radiotherapy induces persistent reduction of sympathetic activity in a hypertensive swine model[J]. J Am Heart Assoc,2021,10(16):e020068.
[25] Zhu ZW,Li XP,Gao YW,et al.[Safety and feasibility of stereotactic radiation therapy on porcine ventricular septum:a preliminary study][J]. Zhonghua Xin Xue Guan Bing Za Zhi,2022,50(9):907-912.
[26] Li X ,Zhu Z,Liu J,et al. Septal radioablation therapy for patients with hypertrophic obstructive cardiomyopathy:first-in-human study[J]. Eur Heart J Open,2023,3(3):oead052.
[27]李慧洋,吴俊劼,周鹏,等. 立体定向射波刀放射治疗肥厚型心肌病的基础研究及临床探索[J].复旦学报(医学版),2022,49(3):360-368+383.
[28] Bonomo P,Cipressi S,Desideri I,et al. Stereotactic body radiotherapy with CyberKnife for cardiac malignancies[J]. Tumori,2015,101(3):294-297.
[29] Stergioula A,Pantelis E. Treatment of a primary cardiac angiosarcoma with stereotactic body radiation therapy[J]. Hellenic J Cardiol,2023,72:70-71.
[30] Dhar A,Donovan E,Leong D,et al. Stereotactic Body Radiation Therapy(SBRT) for a patient with a myocardial metastasis:a case report[J]. Curr Oncol,2021,28(1):390-395.
相似文献/References:
[1]白春兰,张军.正五聚蛋白-3:新型心血管病炎性标志物[J].心血管病学进展,2016,(1):87.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.023]
BAI Chunlan,ZHANG Jun.Pentraxin-3: A Novel Inflammation Biomarker for Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2016,(12):87.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.023]
[2]任茂佳,贺文帅,张琪,等.围绝经期对心血管疾病相关危险因素的影响[J].心血管病学进展,2019,(6):911.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.018]
REN Maojia,HE Wenshuai,ZHANG Qi,et al.Effects of Perimenopause on Cardiovascular Risk Factors[J].Advances in Cardiovascular Diseases,2019,(12):911.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.018]
[3]尹琳 黄从新.JP2蛋白和心血管疾病的研究进展[J].心血管病学进展,2019,(7):1004.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.010]
YIN Lin HUANG Congxin.Research Progress of JP2 Protein and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(12):1004.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.010]
[4]朱峰 汪汉 蔡琳.抗体与心血管疾病[J].心血管病学进展,2019,(7):1007.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.011]
ZHU FengWANG HanCAI Lin.Antibodies and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(12):1007.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.011]
[5]邱明仙 王正龙 许官学.心肌肌球蛋白结合蛋白-C磷酸化与心血管疾病关系的研究进展[J].心血管病学进展,2019,(7):1015.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.013]
QIU MingxianWANG ZhenglongXU Guanxue.Research Progress of the Relationship Between Cardiac Myosin Binding Protein-C and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(12):1015.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.013]
[6]姬楠楠 杨晓静 谢勇.单核细胞/高密度脂蛋白比值与心血管疾病的研究进展[J].心血管病学进展,2019,(7):1019.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.014]
JI Nannan YANG Xiaojing XIE Yong.Monocyte/High-density Lipoprotein Ratio and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(12):1019.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.014]
[7]渠海贤 李涛 程流泉.人工智能在心脏磁共振成像中的应用进展[J].心血管病学进展,2019,(5):659.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.001]
[8]侯冬华 郝丽荣.长正五聚蛋白3在动脉粥样硬化和心血管疾病中作用研究的新进展[J].心血管病学进展,2019,(5):805.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.035]
HOU Donghua H AO Lirong.The Study of Atherosclerosis and Cardiovascular Diseases with Pentapycin 3[J].Advances in Cardiovascular Diseases,2019,(12):805.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.035]
[9]张维 张恒 康品方.外泌体在心血管疾病中的研究进展[J].心血管病学进展,2019,(5):818.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.038]
Zhang WeiKang Pinfang.Exosome in Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2019,(12):818.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.038]
[10]韦莹 刘书旺 李蕾 崔鸣.生长分化因子-15在心房颤动中的研究进展[J].心血管病学进展,2019,(8):1073.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.001]
WEI Ying,LIU Shuwang,LI Lei,et al.Growth Differentiation Factor-15 in Development of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2019,(12):1073.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.001]